Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, July 25, 2023
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
[ Tue, Jul 25th 2023
] - WOPRAI
Ami Fadia Reiterated (BIIB) at Strong Buy and Held Target at $320 on, Jul 25th, 2023
Ami Fadia of Needham, Reiterated "Biogen Inc." (BIIB) at Strong Buy and Held Target at $320 on, Jul 25th, 2023.
Ami has made no other calls on BIIB in the last 4 months.
There are 14 other peers that have a rating on BIIB. Out of the 14 peers that are also analyzing BIIB, 3 agree with Ami's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Laura Chico of "Wedbush" Reiterated at Hold and Held Target at $263 on, Tuesday, May 23rd, 2023
- Geoff Meacham of "B of A Securities" Maintained at Hold with Increased Target to $320 on, Thursday, May 4th, 2023
- Steve Chesney of "Atlantic Equities" Maintained at Hold with Decreased Target to $282 on, Wednesday, April 26th, 2023
These are the ratings of the 11 analyists that currently disagree with Ami
- Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $341 on, Tuesday, July 11th, 2023
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $355 on, Tuesday, July 11th, 2023
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $325 on, Friday, July 7th, 2023
- Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $360 on, Monday, June 12th, 2023
- Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $350 on, Monday, June 12th, 2023
- Carter Gould of "Barclays" Maintained at Buy on, Thursday, June 8th, 2023
- Brian Skorney of "Baird" Reiterated at Buy and Held Target at $340 on, Wednesday, June 7th, 2023
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $360 on, Thursday, June 1st, 2023
- Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Increased Target to $350 on, Thursday, May 11th, 2023
- Yatin Suneja of "Guggenheim" Upgraded from Hold to Strong Buy and Increased Target to $350 on, Monday, May 1st, 2023
- Matthew Korn of "Morgan Stanley" Maintained at Buy with Decreased Target to $349 on, Wednesday, April 12th, 2023
